Capecitabine/cisplatin doublet in anthracycline and taxane pretreated and HER-2 negative metastatic breast carcinoma patients

Ozdemir, N.; Aksoy, S.; Sendur, M.; Akinci, M.; Yazici, O.; Budakoglu, B.; Abali, H.; Oksuzoglu, B.; Zengin, N.

Capecitabine/cisplatin doublet in anthracycline and taxane pretreated and HER-2 negative metastatic breast carcinoma patients

Copy For Citation

Ozdemir N., Aksoy S., Sendur M. A. N., Akinci M. B., Yazici O., Budakoglu B., ...More

JOURNAL OF BUON, vol.18, no.4, pp.831-837, 2013 (SCI-Expanded)

Publication Type: Article / Article
Volume: 18 Issue: 4
Publication Date: 2013
Journal Name: JOURNAL OF BUON
Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Page Numbers: pp.831-837
Hacettepe University Affiliated: Yes

Abstract

Purpose: To evaluate the activity and toxicity of the combination of capecitabine and cisplatin (CapCisp) in anthracycline- and taxane-pretreated HER-2 negative metastatic breast carcinoma (MBC) female patients.